This study, called UROSCOUT-1, is looking at a new way to detect urothelial cancer (cancer of the bladder or upper urinary tract) using a urine test. Currently, if you have blood in your urine (hematuria) or other reasons to suspect urothelial cancer, you often need a cystoscopy, which is an invasive procedure. This study wants to see if a urine tumor DNA (utDNA) test can accurately find cancer, potentially reducing the need for many cystoscopies. We are looking for 3000 participants aged 18 to 100 who are scheduled for a cystoscopy to check for urothelial cancer and have not had a prior diagnosis of this type of cancer. The study will measure how well the utDNA test works at detecting cancer one year after your initial diagnostic workup. The study status is currently unclear.

Study design

This is an observational study planning to enroll 3000 participants. It is not a randomized trial.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured at 1 year after diagnostic workup, suggesting a follow-up period of at least one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.